Insurance Denied Addiction Rehab? Here's How to Appeal

Addiction treatment denials are not just financially devastating — they can be life-threatening. Insurance companies frequently deny inpatient rehab, residential treatment, medication-assisted treatment (MAT), and outpatient programs using criteria that courts and regulators have repeatedly found to be discriminatory and illegal. Here is how to fight back.

Mental Health Parity Act (MHPAEA) Explained" class="auto-link">mhpaea">Federal Law Is on Your Side: MHPAEA

The Mental Health Parity and Addiction Equity Act (MHPAEA) is federal law. It prohibits health insurers from applying more restrictive coverage limitations to mental health and substance use disorder (SUD) benefits than they apply to comparable medical or surgical benefits.

What this means in practice:

• If your plan covers unlimited days for cancer treatment, it cannot impose a 30-day cap on residential rehab
• If your plan doesn't require Prior Authorization Denied: How to Appeal" class="auto-link">prior authorization for cardiac care, it cannot require it for SUD treatment
• Step-therapy requirements that apply to SUD drugs but not to other medications may violate parity

Every denied rehab claim should be evaluated for MHPAEA violations. Request a Comparative Analysis from your insurer (required under the Consolidated Appropriations Act of 2021) showing how they apply SUD coverage rules compared to medical/surgical benefits.

The Wit v. United Behavioral Health Ruling

In 2019, a federal judge ruled in Wit v. United Behavioral Health that UnitedHealth used internally developed guidelines to deny mental health and SUD claims that were more restrictive than generally accepted standards of care. Although the ruling has been through subsequent appeals, it established a critical principle: insurers cannot use their own proprietary criteria to deny care when those criteria deviate from accepted clinical standards like ASAM.

If your insurer denied rehab using criteria that go beyond ASAM Level of Care guidelines, cite Wit v. United Behavioral Health in your appeal and argue that only ASAM criteria should govern your care determination.

ASAM Criteria: The Clinical Standard

The American Society of Addiction Medicine (ASAM) Patient Placement Criteria is the nationally recognized standard for determining the appropriate level of care for substance use disorder treatment. ASAM defines six levels of care:

• Level 0.5: Early intervention
• Level 1: Outpatient treatment
• Level 2: Intensive outpatient program (IOP) / partial hospitalization program (PHP)
• Level 3: Residential/inpatient treatment
• Level 4: Medically managed intensive inpatient treatment (detox)

ASAM placement decisions are based on six dimensions: intoxication/withdrawal potential, biomedical conditions, emotional/cognitive conditions, readiness to change, relapse potential, and recovery environment.

If your insurer denied Level 3 residential care and approved only Level 1 outpatient, your appeal should argue that your ASAM dimensional assessment supports residential placement — particularly if you have a history of relapse in lower levels of care, co-occurring mental health conditions, or an unsafe home environment.

Medication-Assisted Treatment (MAT) Denials

MAT — including buprenorphine (Suboxone), methadone, and naltrexone (Vivitrol) — is the gold standard evidence-based treatment for opioid use disorder (OUD). The Substance Abuse and Mental Health Services Administration (SAMHSA) and all major medical associations support MAT as first-line treatment.

Common MAT denials and how to fight them:

Step therapy requiring abstinence-based treatment first: This is potentially a MHPAEA violation. Requiring patients to fail abstinence-only programs before accessing Suboxone has no equivalent in medical/surgical coverage.

Quantity or duration limits on buprenorphine: SAMHSA and ASAM support long-term, indefinite MAT for many patients. Duration limits should be challenged as medically unsupported.

Prior authorization denials for Suboxone: Request peer-to-peer review between your prescribing physician and the insurer's medical director. Have your physician cite ASAM's National Practice Guideline for MAT.

Building Your Rehab Appeal

A strong substance use disorder appeal includes:

1. Clinical assessment: ASAM-based assessment from your treating provider documenting the appropriate level of care
2. Treatment history: Prior treatment episodes and outcomes, including any relapses that support higher-level care
3. Medical necessity letter: Physician letter citing ASAM criteria, specific dimensional scores, and functional impairment
4. MHPAEA analysis: Comparison of SUD coverage restrictions to medical/surgical benefit restrictions
5. Comparative Analysis request: Formally demand the insurer's MHPAEA comparative analysis in writing

State Parity Laws and Regulators

Most states have their own parity laws that may provide stronger protections than federal MHPAEA. If your appeal is denied at the internal level, file a complaint with your state insurance commissioner and request an external independent review. Many states now have dedicated SUD parity enforcement units.

You can also contact your state's SUD ombudsman program or patient advocacy organizations such as the National Alliance on Mental Illness (NAMI) or the Addiction Policy Forum for assistance navigating the appeals process.

Fight Back With ClaimBack

Addiction rehab denials are frequently overturned on appeal — especially when MHPAEA parity arguments and ASAM criteria are properly presented. ClaimBack helps you build a clinically grounded, legally informed appeal that holds your insurer accountable to federal law.

Start your addiction rehab appeal at ClaimBack

Related Reading

• What Is Medical Necessity?
• Internal vs External Insurance Appeal: Which Should You File?
• How to Write an Insurance Appeal Letter